IMMUNOLOGY FOR A NEW FUTURE
Mission of NuraVax is to develop effective and affordable preventive treatment of Alzheimer’s and oter currently untreatable deceases
© 2021 NuraVax | Copyright
01
16371 Gothard St., H Huntington Beach, CA, 92647
BIOTECH COMPANY
OUR SCIENCE
Taken a challenge to cure people from CNS disease NuraVax took Alzheimer as a primary focus. NuraVax developed wide spectrum of products based on universal platform vaccine solution MultiTEP which is able to deal with most problems, scientists face with, when they work at brain diseases.
02
PIPELINE
It took almost 20 years for the NuraVax team to develop and characterize this 3rd generation platform and develop multiple vaccines for elderly people at risk of AD, tauopathies, PD, and α-synucleopathies using mostly NIA and NINDS R21s, R01s, and U01 awards. Of note, because of these data, recently, NIA leadership supported the development of a SARS-CoV-2 MultiTEP-based vaccine for the elderly.
03
PIPELINE
CONTACT
+1 (714) 330-6648
info@nuravax.com
16371 Gothard St., H Huntington Beach, CA, 92647
Phone
E-mail
Address
06